The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Myelofibrosis prognostic models validated in an underserved minority population: A retrospective analysis.
 
Josette Mary Kamel
No Relationships to Disclose
 
John Yan
No Relationships to Disclose
 
Mendel Goldfinger
No Relationships to Disclose
 
Eric J. Feldman
No Relationships to Disclose
 
Marina Konopleva
Honoraria - Abbvie; Amgen; Forty Seven; Genentech; Roche; Stemline Therapeutics
Consulting or Advisory Role - AbbVie; Amgen; AstraZeneca; Forty Seven; Genentech/Roche; Gilead/Forty Seven; Janssen; MEI Pharma; Roche; Sanofi/Aventis; Stemline Therapeutics; Vincerx Pharma
Research Funding - Abbvie (Inst); Ablynx (Inst); Allogene Therapeutics; AstraZeneca (Inst); Cellectis (Inst); Daiichi Sankyo/Lilly; Forty Seven (Inst); Genentech (Inst); Gilead/Forty Seven; Immunogen; MEI Pharma; Precision Biosciences; Rafael Pharmaceuticals; Sanofi (Inst); Stemline Therapeutics
Patents, Royalties, Other Intellectual Property - Reata pharmaceutical - Research Funding- (Issued, Licensed, Royalities)
 
Ioannis Mantzaris
No Relationships to Disclose
 
Aditi Shastri
Honoraria - OncLive
Consulting or Advisory Role - Gerson Lehrman, Guidepoint Global
Research Funding - Kymera
 
Noah Kornblum
No Relationships to Disclose
 
Kira Gritsman
No Relationships to Disclose
 
Alejandro R. Sica
No Relationships to Disclose
 
Nishi Shah
No Relationships to Disclose
 
Dennis Cooper
No Relationships to Disclose
 
Amit Verma
Leadership - Novasenta (I)
Stock and Other Ownership Interests - Stelexis Therapeutics
Consulting or Advisory Role - Curis, BMS, Aurigene
Research Funding - GlaxoSimthLine, BMS, Jannsen, Incyte, MedPacto, Colegene, Novartis, Curis, Prelude, Eli Lilly
 
Swati Goel
No Relationships to Disclose